Research and consumer demand are validating the need for health and comfort designed into the home, but there are still challenges to bring it all toget
With the rise in premiums and deductibles not included in the CPI increase, it’s evident that certain healthcare costs are enhancing the affordability crisis.
A neurosurgeon explains what the 3.6% Social Security COLA for 2027 means for Medicare patients and its potential impact during the open enrollment period.
Whole-genome testing uncovered hidden cancer predisposition in children with leukemia, changing treatment and surveillance in a nationwide Swedish study.
In this week’s edition of InnovationRx, the bumper crop of biotech IPOs, Isomorphic’s reported $40 billion valuation fundraise, and the impact of drugmakers’ gifts to doctors.
“The Last Ditch Bar controversy reveals a deeper story: what it actually costs to live immunocompromised in a world that’s moved on from masks.”
Long-read DNA testing diagnosed 35% of previously unsolved inherited muscle disease cases, detecting complex genetic changes missed by standard tests.
Humana has “entered a new joint venture agreement” with a BlackRock investment unit to manage and operate its network of 150 CenterWell primary care clinics.
UnitedHealth Group’s third quarter net income eclipsed $4 billion as the healthcare giant keeps previously uncontrolled medical costs in check in its health plans.
A former Susan G. Komen CEO’s new institute wants breast arterial calcification, a heart disease marker, on every mammogram report. No clinical guideline exists yet.